{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:45:28Z","timestamp":1792986328140,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Fight against Cancer","doi-asserted-by":"publisher","award":["13899"],"award-info":[{"award-number":["13899"]}],"id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.radonc.2025.110936","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:32:47Z","timestamp":1746988367000},"page":"110936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Systematic review of MRI alterations in the brain following proton and photon radiation therapy: Towards a uniform European Particle Therapy Network (EPTN) definition"],"prefix":"10.1016","volume":"208","author":[{"given":"Lieselotte","family":"Lauwens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin F.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina M.L.","family":"Zegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton","family":"H\u00f8yer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Alapetite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Blomstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Calugaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Iannalfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"L\u00fctgendorf-Caucig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida A.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra M\u00e9nd\u00e8z","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiska L.","family":"van der Weide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Harrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle B.P.","family":"Eekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110936_b0005","first-page":"18","article-title":"Late effects of cancer treatment: Consequences for long-term brain cancer survivors","volume":"8","author":"Alemany","year":"2021","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2025.110936_b0010","unstructured":"Particle Therapy Co-opreative Group (PTCOG) n.d. https:\/\/ptcog.site\/index.php\/facilities-in-operation-public (accessed October 7, 2024)."},{"key":"10.1016\/j.radonc.2025.110936_b0015","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1002\/mp.13390","article-title":"Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy","volume":"46","author":"Paganetti","year":"2019","journal-title":"Medical Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.radonc.2022.05.015","article-title":"Clinical use and future requirements of relative biological effectiveness: Survey among all European proton therapy centres","volume":"172","author":"Heuchel","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2022.01.018","article-title":"The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation","volume":"168","author":"De Roeck","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2021.05.013","article-title":"Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology","volume":"160","author":"Eekers","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","article-title":"Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus","volume":"128","author":"Lambrecht","year":"2018","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0040","first-page":"372","article-title":"statement: An updated guideline for reporting systematic reviews","volume":"2021","author":"Page","year":"2020","journal-title":"The BMJ"},{"key":"10.1016\/j.radonc.2025.110936_b0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in endnote","volume":"104","author":"Bramer","year":"2016","journal-title":"Journal of the Medical Library Association"},{"key":"10.1016\/j.radonc.2025.110936_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1016\/j.radonc.2025.110936_b0055","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses 2014."},{"key":"10.1016\/j.radonc.2025.110936_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14338\/IJPT-20-00014.1","article-title":"Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base","volume":"6","author":"Kitpanit","year":"2020","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2025.110936_b0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hed.27315","article-title":"Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity-modulated radiotherapy treatment of T4 nasopharyngeal carcinoma","volume":"45","author":"Chen","year":"2023","journal-title":"Head & Neck"},{"key":"10.1016\/j.radonc.2025.110936_b0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2014.10.011","article-title":"Dose volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy","volume":"91","author":"McDonald","year":"2015","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0075","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ijrobp.2022.01.047","article-title":"PHYSICS CONTRIBUTION NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors","volume":"113","author":"Schr\u00f6der","year":"2022","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110936_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/radiol.14141721","article-title":"Normal tissue complication probability model for radiationinduced temporal lobe injury after intensity-modulated radiation therapy for nasopharyngeal carcinoma","volume":"276","author":"Zeng","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2025.110936_b0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2019.01.002","article-title":"Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma","volume":"104","author":"Wu","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0090","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00066-014-0608-2","article-title":"Active raster scanning with carbon ions. Reirradiation in patients with recurrent skull base chordomas and chondrosarcomas","volume":"190","author":"Uhl","year":"2014","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2025.110936_b0095","doi-asserted-by":"crossref","unstructured":"Zhang YY, Huo WL, Goldberg SI, Slater JM, Adams JA, Deng XW, et al. Brain-Specific Relative Biological Effectiveness of Protons Based on Long-term Outcome of Patients With Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys, vol. 110, Elsevier Inc.; 2021, p. 984\u201392. doi: 10.1016\/j.ijrobp.2021.02.018.","DOI":"10.1016\/j.ijrobp.2021.02.018"},{"key":"10.1016\/j.radonc.2025.110936_b0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/cam4.1291","article-title":"Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.radonc.2025.110936_b0105","article-title":"Development and Validation of a Nomogram for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma. Front","volume":"10","author":"Guan","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2025.110936_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1229-9","article-title":"Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: A competing risk study","volume":"14","author":"Huang","year":"2019","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4143\/crt.2017.551","article-title":"The characteristics and survival outcomes in patients aged 70 years and older with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era","volume":"51","author":"Jin","year":"2019","journal-title":"Cancer Research and Treatment"},{"key":"10.1016\/j.radonc.2025.110936_b0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-014-1513-3","article-title":"Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors","volume":"119","author":"Liu","year":"2014","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.07.020","article-title":"Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients","volume":"85","author":"Lu","year":"2018","journal-title":"Oral Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2021.01.008","article-title":"Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China","volume":"157","author":"Wen","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1148\/radiol.09090428","article-title":"Evolution of radiation-induced brain injury: MR imaging-based study","volume":"254","author":"Wang","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2025.110936_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110258","article-title":"Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis","volume":"195","author":"Dong","year":"2024","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0145","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/0284186X.2014.957414","article-title":"Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy","volume":"53","author":"Indelicato","year":"2014","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2025.110936_b0150","doi-asserted-by":"crossref","unstructured":"Indelicato DJ, Ioakeim-Ioannidou M, Bradley JA, Mailhot-Vega RB, Morris CG, Tarbell NJ, et al. Proton Therapy for Pediatric Ependymoma: Mature Results From a Bicentric Study. Int J Radiat Oncol Biol Phys, vol. 110, Elsevier Inc.; 2021, p. 815\u201320. doi: 10.1016\/j.ijrobp.2021.01.027.","DOI":"10.1016\/j.ijrobp.2021.01.027"},{"key":"10.1016\/j.radonc.2025.110936_b0155","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/neuonc\/noac044","article-title":"Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors","volume":"24","author":"Upadhyay","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110157","article-title":"Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: A French retrospective study","volume":"194","author":"Dalmasso","year":"2024","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0165","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1080\/0284186X.2019.1659996","article-title":"Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy","volume":"58","author":"Vogel","year":"2019","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2025.110936_b0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14338\/IJPT-22-00008.1","article-title":"Brainstem Toxicity in Pediatric Patients Treated with Protons Using a Single-vault Synchrocyclotron System","volume":"9","author":"Orukari","year":"2022","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2025.110936_b0175","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2017.11.026","article-title":"Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors","volume":"100","author":"Gentile","year":"2018","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09213-z","article-title":"Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT","volume":"22","author":"Fan","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.110936_b0185","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2019.08.039","article-title":"Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation","volume":"105","author":"Devine","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-1105-z","article-title":"A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: Radiation-induced brainstem injury and dose-volume analysis","volume":"13","author":"Yao","year":"2018","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.oraloncology.2017.08.011","article-title":"Incidence and dosimetric parameters for brainstem necrosis following intensity modulated radiation therapy in nasopharyngeal carcinoma","volume":"73","author":"Li","year":"2017","journal-title":"Oral Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.04.032","article-title":"Evolution and Dosimetric Analysis of Magnetic Resonance Imaging\u2013Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma","volume":"105","author":"Huang","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2017.09.040","article-title":"Sequential proton boost after standard chemoradiation for high-grade glioma","volume":"125","author":"Adeberg","year":"2017","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0210","first-page":"128","article-title":"Evaluation of pseudoprogression in patients with glioblastoma","volume":"4","author":"Kucharczyk","year":"2017","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2025.110936_b0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clineuro.2016.10.004","article-title":"IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy","volume":"151","author":"Li","year":"2016","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.radonc.2025.110936_b0220","first-page":"185","article-title":"Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: A multi-institutional experience","volume":"7","author":"Mohammadi","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2025.110936_b0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1634\/theoncologist.2013-0101","article-title":"Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation","volume":"19","author":"Pinho","year":"2014","journal-title":"The Oncologist"},{"key":"10.1016\/j.radonc.2025.110936_b0230","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noad247","article-title":"Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide","author":"Flies","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0235","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/neuonc\/now091","article-title":"Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy\/temozolomide for newly diagnosed glioblastoma","volume":"18","author":"Wick","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0240","first-page":"719","article-title":"Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy","volume":"19","author":"Van West","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109674","article-title":"Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma","volume":"184","author":"Jaspers","year":"2023","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/neuonc\/noac194","article-title":"Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: APOLA network study","volume":"25","author":"Seyve","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/0284186X.2023.2200150","article-title":"Transitioning from conventional photon therapy to proton therapy for primary brain tumors","volume":"62","author":"Ek","year":"2023","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2025.110936_b0260","article-title":"Retrospective examination of pseudoprogression in IDH mutant gliomas","volume":"5","author":"Wetzel","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.radonc.2025.110936_b0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/not142","article-title":"Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas","volume":"16","author":"Lin","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0270","first-page":"30","article-title":"Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma","volume":"9","author":"Bronk","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110936_b0275","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1002\/onco.13701","article-title":"Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort","volume":"26","author":"Esteyrie","year":"2021","journal-title":"The Oncologist"},{"key":"10.1016\/j.radonc.2025.110936_b0280","article-title":"Reduced volume intensity-modulated radiotherapy with simultaneous integrated boost for patients with high-grade glioma: A retrospective observational study","volume":"102","author":"Kang","year":"2023","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.radonc.2025.110936_b0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10147-014-0690-6","article-title":"Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features","volume":"20","author":"Lim","year":"2015","journal-title":"International Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11060-021-03734-6","article-title":"Distinct imaging patterns of pseudoprogression in glioma patients following proton versus photon radiation therapy","volume":"152","author":"Ritterbusch","year":"2021","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11060-018-03063-1","article-title":"Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide","volume":"142","author":"Dworkin","year":"2019","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0300","first-page":"36","article-title":"Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study","volume":"11","author":"Blakstad","year":"2024","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2025.110936_b0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2019.01.078","article-title":"Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma","volume":"104","author":"Indelicato","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pbc.25179","article-title":"Pseudoprogression of low-grade gliomas after radiotherapy","volume":"62","author":"Naftel","year":"2015","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1016\/j.radonc.2025.110936_b0315","doi-asserted-by":"crossref","first-page":"291","DOI":"10.14338\/IJPT-16-00020.1","article-title":"Extended Volumetric Follow-up of Juvenile Pilocytic Astrocytomas Treated with Proton Beam Therapy","volume":"3","author":"Mannina","year":"2016","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2025.110936_b0320","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/neuonc\/noz042","article-title":"Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy","volume":"21","author":"Ludmir","year":"2019","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0325","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11060-017-2583-9","article-title":"Pseudoprogression in pediatric low-grade glioma after irradiation","volume":"135","author":"Tsang","year":"2017","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0330","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2021.12.007","article-title":"Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort","volume":"112","author":"Stock","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0335","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-016-2151-8","article-title":"Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma","volume":"129","author":"Carceller","year":"2016","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0340","unstructured":"Bhattacharya D, Chhabda S, Lakshmanan R, Tan R, Warne R, Benenati M, et al. Spectrum of neuroimaging findings post-proton beam therapy in a large pediatric cohort n.d. doi: 10.1007\/s00381-020-04819-9\/Published."},{"key":"10.1016\/j.radonc.2025.110936_b0345","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0350","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-016-0507-6","article-title":"Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials","volume":"14","author":"Ellingson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.radonc.2025.110936_b0360","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3174\/ajnr.A4333","article-title":"Radiation necrosis in pediatric patients with brain tumors treated with proton radiotherapy","volume":"36","author":"Kralik","year":"2015","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.radonc.2025.110936_b0365","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ijrobp.2024.01.007","article-title":"Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors","volume":"118","author":"Lutgendorf-Caucig","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0370","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/neuonc\/noad244","article-title":"Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial","volume":"26","author":"Deng","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0375","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2020.03.013","article-title":"Late Contrast Enhancing Brain Lesions in Proton-Treated Patients With Low-Grade Glioma: Clinical Evidence for Increased Periventricular Sensitivity and Variable RBE","volume":"107","author":"Bahn","year":"2020","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2021.12.035","article-title":"Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma \u2013 How safe are protons?","volume":"167","author":"Harrabi","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0385","doi-asserted-by":"crossref","unstructured":"Eulitz J, G. C. Troost E, Kl\u00fcnder L, Raschke F, Hahn C, Schulz E, et al. Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients. Radiotherapy and Oncology 2023;178. doi: 10.1016\/j.radonc.2022.11.011.","DOI":"10.1016\/j.radonc.2022.11.011"},{"key":"10.1016\/j.radonc.2025.110936_b0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2021.08.015","article-title":"Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors","volume":"163","author":"Garbacz","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0395","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2022.05.005","article-title":"Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults","volume":"172","author":"Eichkorn","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0400","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11060-022-04217-y","article-title":"Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3","volume":"162","author":"Eichkorn","year":"2023","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0405","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2017.11.037","article-title":"Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy","volume":"100","author":"Bojaxhiu","year":"2018","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2013.11.005","article-title":"Risk factors for brain injury after carbon ion radiotherapy for skull base tumors","volume":"111","author":"Koto","year":"2014","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0415","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-021-03758-y","article-title":"Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy","volume":"153","author":"Song","year":"2021","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0420","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/08880018.2013.791738","article-title":"Cerebral radiation necrosis in pediatric patients","volume":"32","author":"Plimpton","year":"2015","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0425","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0430","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2020.07.008","article-title":"Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers","volume":"151","author":"Engeseth","year":"2020","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0435","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ijrobp.2022.09.081","article-title":"Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015","volume":"115","author":"Flechl","year":"2023","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0440","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.radonc.2021.10.017","article-title":"Predicted probabilities of brain injury after carbon ion radiotherapy for head and neck and skull base tumors in long-term survivors","volume":"165","author":"Park","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0445","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijrobp.2019.06.2534","article-title":"Biologic Dose and Imaging Changes in Pediatric Brain Tumor Patients Receiving Spot Scanning Proton Therapy","volume":"105","author":"Roberts","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0450","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2018.01.099","article-title":"Association of 1p\/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy","volume":"101","author":"Acharya","year":"2018","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0455","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3174\/ajnr.A7156","article-title":"Cystlike lesions as a late sequela of radiotherapy in pediatric patients","volume":"42","author":"Veiga","year":"2021","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.radonc.2025.110936_b0460","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00381-017-3400-7","article-title":"Development of cystic malacia after high-dose cranial irradiation of pediatric CNS tumors in long-term follow-up","volume":"33","author":"Yamasaki","year":"2017","journal-title":"Child\u2019s Nervous System"},{"key":"10.1016\/j.radonc.2025.110936_b0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89216-1","article-title":"Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors","volume":"11","author":"Terziev","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.radonc.2025.110936_b0470","article-title":"MR imaging evaluation of intracerebral hemorrhages and T2 hyperintense white matter lesions appearing after radiation therapy in adult patients with primary brain tumors","volume":"10","author":"Yoo","year":"2015","journal-title":"PLoS One1"},{"key":"10.1016\/j.radonc.2025.110936_b0475","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.radonc.2016.11.001","article-title":"Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma","volume":"121","author":"Peeler","year":"2016","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0480","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ijrobp.2014.05.541","article-title":"Comparison of Imaging Changes in Pediatric Patients Treated With Proton Beam Radiation Therapy Versus Intensity Modulated Radiation Therapy for Intra-cranial Ependymoma","volume":"90","author":"Gunther","year":"2014","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0485","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2017.08.021","article-title":"Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy","volume":"99","author":"Patay","year":"2017","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0490","doi-asserted-by":"crossref","first-page":"e640","DOI":"10.1016\/j.wneu.2018.09.179","article-title":"Fractionated Radiotherapy Is Associated with Lower Rates of Treatment-Related Edema than Stereotactic Radiosurgery in Magnetic Resonance Imaging\u2013Defined Meningiomas","volume":"121","author":"Morgan","year":"2019","journal-title":"World Neurosurgery"},{"key":"10.1016\/j.radonc.2025.110936_b0495","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11060-017-2536-3","article-title":"Aberrant paramagnetic signals outside the tumor volume on routine surveillance MRI of brain tumor patients","volume":"134","author":"Yust-Katz","year":"2017","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0500","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.ijrobp.2018.07.2016","article-title":"Radiation-Induced Cerebral Microbleeds in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy","volume":"102","author":"Kralik","year":"2018","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0505","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1007\/s00330-018-5356-8","article-title":"Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy","volume":"28","author":"Lecler","year":"2018","journal-title":"European Radiology"},{"key":"10.1016\/j.radonc.2025.110936_b0510","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.radonc.2015.09.017","article-title":"A comparative study of the extent of cerebral microvascular injury following whole-brain irradiation versus reduced-field irradiation in long-term survivors of intracranial germ cell tumors","volume":"117","author":"Li","year":"2015","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0515","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jocn.2017.09.008","article-title":"High prevalence of small vessel disease long after cranial irradiation","volume":"46","author":"Miura","year":"2017","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.radonc.2025.110936_b0520","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.radonc.2018.03.010","article-title":"Susceptibility-weighted magnetic resonance imaging of cerebrovascular sequelae after radiotherapy for pediatric brain tumors","volume":"127","author":"Neu","year":"2018","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0525","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jns.2016.11.005","article-title":"Microbleeds and cavernomas after radiotherapy for paediatric primary brain tumours","volume":"372","author":"Passos","year":"2017","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.radonc.2025.110936_b0530","unstructured":"Roongpiboonsopit D, Kuijf HJ, Charidimou A, Xiong L, Vashkevich A, Sergi Martinez-Ramirez BA, et al. Evolution of cerebral microbleeds after cranial irradiation in medulloblastoma patients. vol. 22. 2024."},{"key":"10.1016\/j.radonc.2025.110936_b0535","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-017-0861-5","article-title":"Relationship between radiation dose and microbleed formation in patients with malignant glioma","volume":"12","author":"Wahl","year":"2017","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0540","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/neuonc\/now082.02","article-title":"Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors","volume":"18","author":"Roddy","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0545","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11060-014-1390-9","article-title":"Natural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy","volume":"117","author":"Di Giannatale","year":"2014","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0550","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00381-015-2626-5","article-title":"The postirradiation incidence of cavernous angioma is higher in patients with childhood pineoblastoma or primitive neuroectodermal tumors than medulloblastoma","volume":"31","author":"Yamasaki","year":"2015","journal-title":"Child\u2019s Nervous System"},{"key":"10.1016\/j.radonc.2025.110936_b0555","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Cerebral microbleeds: a guide to detection and interpretation","volume":"8","author":"Greenberg","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.radonc.2025.110936_b0560","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2019.07.013","article-title":"Pseudoprogression after radiation therapies for low grade glioma in children and adults: A systematic review and meta-analysis","volume":"142","author":"Lu","year":"2020","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0565","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.23.01059","article-title":"RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults","volume":"41","author":"Wen","year":"2023","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2022.08.014","article-title":"A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE)","volume":"175","author":"Underwood","year":"2022","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0575","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2021.06.016","article-title":"Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer","volume":"111","author":"Engeseth","year":"2021","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110716","article-title":"Mixed effect model confirms increased risk of image changes with increasing linear energy transfer in proton therapy of gliomas","volume":"204","author":"Vestergaard","year":"2025","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2025.110936_b0585","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2021.08.027","article-title":"Correlation of LET With MRI Changes in Brain and Potential Implications for Normal Tissue Complication Probability for Patients With Meningioma Treated With Pencil Beam Scanning Proton Therapy","volume":"112","author":"Bertolet","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110936_b0590","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/0284186X.2018.1468090","article-title":"Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?","volume":"57","author":"Giantsoudi","year":"2018","journal-title":"Acta Oncol (Madr)"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:40:06Z","timestamp":1762256406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":118,"alternative-id":["S0167814025002312"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110936","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of MRI alterations in the brain following proton and photon radiation therapy: Towards a uniform European Particle Therapy Network (EPTN) definition","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110936"}}